TTToru Tanaka

Toru Tanaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Toru Tanaka has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Atsumasa Okada

    Laboratory of Stem Cell Regulation, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki City, Osaka, 567-0085, Japan

    1 shared publication
  • Hayato Matsui

    Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, 565-0871, Japan

    1 shared publication
  • Hiroyuki Mizuguchi

    Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, 565-0871, Japan

    1 shared publication
  • Keisuke Shirakura

    Affiliation Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany

    1 shared publication
  • Kenji Ishimoto

    Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, 565-0871, Japan

    1 shared publication
  • Kenji Kawabata

    Laboratory of Stem Cell Regulation, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki City, Osaka, 567-0085, Japan

    1 shared publication

Latest Publications

  • Open Access

    ETV2-TET1/TET2 Complexes Induce Endothelial Cell-Specific Robo4 Expression via Promoter Demethylation

    by Toru Tanaka, Kohei Izawa, Yusuke Maniwa, Maki Okamura, Atsumasa Okada, Tomoko Yamaguchi, Keisuke Shirakura, Naoki Maekawa, Hayato Matsui, Kenji Ishimoto, et al.

    Although transcription factors regulating endothelial cell (EC)-specific gene expression have been identified, it is not known how those factors induce EC-specificity. We previously reported that DNA hypomethylation of the proximal promoter elicits EC-specific expression of Roundabout4 (Robo4). However, the mechanisms establishing EC-specific hypomethylation of the Robo4 promoter remain unknown. In this study, we demonstrated that the hypermethylated Robo4 proximal promoter is demethylated as human iPS cells differentiate into endothelial cells. Reporter assays demonstrated that ETV2, an ETS family transcription factor, bound to ETS motifs in the proximal promoter and activated Robo4 expression. Immunoprecipitation demonstrated direct interaction between ETV2 and methylcytosine-converting enzymes TET1 and TET2. Adenoviral expression of ETV2-TET1/TET2 complexes demethylated the Robo4 promoter and induced Robo4 expression in non-ECs. In summary, we propose a novel regulatory model of EC-specific gene expression via promoter demethylation induced by ETV2-TET1/TET2 complexes during endothelial differentiation.